Status:
RECRUITING
Light Therapy in Parkinson's Disease
Lead Sponsor:
Second Affiliated Hospital of Soochow University
Conditions:
Parkinson Disease
Sleep Disorder
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
The aim of this randomized controlled trial (RCT) is to clarify the effect of bright light therapy on motor symptoms and sleep disorders in patients with Parkinson's disease.
Detailed Description
As the most important biologic rhythm timer, exogenous light supplement has certain benefits for the improvement of sleep quality and dementia. At present, it is gradually used in sleep and neuropsych...
Eligibility Criteria
Inclusion
- According to the criteria of PD diagnosis of the MDS, PD patients were selected as the research object. The clinical symptoms of PD patients were consistent with Hoehn and Yahr stages 2-3.
- All PD patients have maintained stable drug treatment for at least one month, signed clinical informed consent and agreed not to adjust drugs throughout the light test and follow-up period.
Exclusion
- Using hypnotic or stimulating drugs.
- Using antidepressants, except stable drugs maintained for more than three months;
- Visual impairment, such as cataract, glaucoma, blindness, etc;
- Cognitive impairment (MMSE \< 24);
- There are uncontrollable hallucinations and mental diseases;
- There are sleep phase delay / advance syndrome, shift work, jet lag, etc
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 16 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06129942
Start Date
September 1 2021
End Date
May 16 2026
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215004